Patent details

EP2736510 Title: METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2736510
WO Application Number:
US2012048641
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12817423.2
WO Publication Number:
WO2013016668
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
27/07/2012
Grant date:
01/03/2017
EP Publication Date:
04/06/2014
WO Publication Date:
31/01/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
31/03/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/03/2017
EP B1 Publication Date:
01/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/07/2032
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
29/04/2024
 
 

 

Name:
Zevra Therapeutics, Inc.
Address:
1180 Celebration Blvd. Suite 103, 34747, Celebration, Florida, United States of America (US)

Historical Applicant/holder

From:
01/10/2019
To:
29/04/2024

 

Name:
Kempharm, Inc.
Address:
1180 Celebration Blvd. Suite 103, 34747, Celebration, Florida, United States of America (US)

From:
01/10/2019
To:
01/10/2019

 

Name:
Kempharm, Inc.
Address:
1180 Celebration Blvd. Suite 103, 34747, Celebration, Florida, United States of America (US)

Agent

Name:
dr. A. Krebs
From:
01/10/2019
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Domicile Holder

Name:
ir. C.W.A.M. Klavers
From:
31/03/2017
Address:
Octrooibureau Klavers B.V. Postbus 1642, 1300 BP, Almere, Netherlands (NL)
To:
08/10/2019

Inventor

1

Name:
GUENTHER, Sven
Address:
Coralville, Iowa 52241, United States of America (US)

2

Name:
CHI, Guochen
Address:
Coralville, Iowa 52241, United States of America (US)

3

Name:
BERA, Bindu
Address:
Blacksburg, Virginia 24060, United States of America (US)

4

Name:
MICKLE, Travis
Address:
Coralville, Iowa 52241, United States of America (US)

5

Name:
BERA, Sanjib
Address:
Blacksburg, Virginia 24060, United States of America (US)

Priority

Priority Patent Number:
201161512658 P
Priority Date:
28/07/2011
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/4458;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
24/24
Publication date:
12/06/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
15/17
Publication date:
19/04/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
09/17
Publication date:
01/03/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201714
Publication date:
05/04/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201709
Publication date:
01/03/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202401057A
Date Registered:
29/04/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. A. Krebs
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Zevra Therapeutics, Inc.
Address:
1180 Celebration Blvd. Suite 103, 34747, Celebration, Florida, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201901979A
Date Registered:
01/10/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. A. Krebs
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2026
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
23/07/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
PAVIS GmbH
Filing date Document type Document Description Number of pages File Type
12/04/2017 Outgoing Correspondence Letter no formal defects 1 PDF /5/2/7/4/3/0800134725/docs/ep12817423.2_2_130607l271.pdf
31/03/2017 Claims First filed claims 5 PDF /5/2/7/4/3/0800134725/docs/ep12817423.2_0_claims20170331144059065.pdf
31/03/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/2/7/4/3/0800134725/docs/ep12817423.2_1_incomingcorrespondenceelectronic20170331144100206.pdf